The following stories appear in full on Today's Vidyya Medical News Service Web site.
Important new, safety information has been added to the prescribing information for Zyvoxtm (linezolid injection, tablets and for oral suspension), a synthetic antibacterial agent of the oxazolidinone class. Zyvox is indicated for the treatment of adult patients with the following infections caused by susceptible strains of designated microorganisms: vancomycin–resistant Enterococcus faecium, including cases with concurrent bacteremia; nosocomial pneumonia; complicated and uncomplicated skin and skin structure infections; and community-acquired pneumonia, including cases with concurrent bacteremia.
For more information: Important Safety Warning: Zyvoxtm (Linezolid Injection, Tablets And For Oral Suspension)
Linezolid is a synthetic antibacterial agent of a new class of antibiotics, the oxazolidinones, which has clinical utility in the treatment of infections caused by aerobic gram-positive bacteria. The in vitro spectrum of activity of linezolid also includes certain gram-negative bacteria and anaerobic bacteria. Get the full prescribing information for Zyvox in today's issue.
For more information: Prescribing Information: Zyvoxtm (Linezolid Injection, Tablets And For Oral Suspension)
A study to be released Wednesday at the Society of Gynecologic Oncologists annual meeting reported that long-term aspirin use may decrease the risk of epithelial ovarian cancer. The study involved 748 patients in a prospective cohort followed-up for an average of 12 years. Initial results suggest that aspirin use three or more times per week for at least six months could be associated with a 40 percent reduction of the epithelial ovarian cancer risk.
For more information: Study To Be Released Wednesday Reports That Long-Term Aspirin Use May Decrease The Risk Of Epithelial Ovarian Cancer
The number of treatment options available to those with psoriasis has nearly doubled in the past few years. And the number of options is continuing to increase as dermatologists study combinations of new therapies and previously available treatments. Some of these combinations are improving patients' quality of life as they prove to be more effective and offer longer periods of remission.
For more information: New Combinations Of Psoriasis Therapies Offer Positive Results
Having asthma may increase a person's risk of heart disease by a third, according to research presented Friday at the American Heart Association's 41st Annual Conference on Cardiovascular Disease Epidemiology and Prevention in San Antonio, Texas.
For more information: Heart Disease Risks Higher for Asthma Patients - Even Non-Smokers
Today's Vidyya articles are:
As always, we hope you enjoy the issue.